atenolol has been researched along with Drop Attack in 30 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The objective of this investigation was the assessment of the response rate of oral atenolol in patients with vasovagal syncope after 1 month of treatment." | 9.08 | Randomized double-blind, placebo-controlled trial of oral atenolol in patients with unexplained syncope and positive upright tilt table test results. ( Bhuripanyo, K; Chaithiraphan, S; Kangkagate, C; Kulchot, B; Mahanonda, N; Nademanee, K; Wansanit, K, 1995) |
| "Significant differences between pre- and posttreatment number of VPC, severity of arrhythmia, HR variables, or occurrence of syncope were not observed in dogs treated with atenolol or procainamide." | 5.10 | Comparison of the effects of four antiarrhythmic treatments for familial ventricular arrhythmias in Boxers. ( Atkins, CE; DeFrancesco, TC; Gordon, SG; Hamlin, RL; Keene, BW; Meurs, KM; Miller, MW; Moise, NS; Spier, AW; Wright, NA, 2002) |
| "The objective of this investigation was the assessment of the response rate of oral atenolol in patients with vasovagal syncope after 1 month of treatment." | 5.08 | Randomized double-blind, placebo-controlled trial of oral atenolol in patients with unexplained syncope and positive upright tilt table test results. ( Bhuripanyo, K; Chaithiraphan, S; Kangkagate, C; Kulchot, B; Mahanonda, N; Nademanee, K; Wansanit, K, 1995) |
| "To study the efficacy of medical treatment for preventing syncopal recurrences in patients affected by tilt-induced neurally mediated syncope, a randomized placebo-treatment prospective study was performed in 30 patients (10 men and 20 women, mean age 42 +/- 21 years) who had syncope reproduced in 2 consecutive head-up tilt-table tests without pharmacologic intervention (n = 20) or during isoproterenol infusion (n = 10)." | 5.07 | A controlled trial of acute and long-term medical therapy in tilt-induced neurally mediated syncope. ( Bottoni, N; Brignole, M; Gianfranchi, L; Lolli, G; Menozzi, C; Oddone, D, 1992) |
| "We report a case of potential cardiovascular toxicity including syncope, bradycardia, and ECG pauses associated with the use of rivastigmine and atenolol." | 4.86 | Potential cardiotoxic reaction involving rivastigmine and beta-blockers: a case report and review of the literature. ( Léos, CL; Paulison, B, 2010) |
| "This study included 87 consecutive patients with unexplained syncope or pre-syncope who had undergone the head-up tilt (HUT) test with concomitant isoproterenol infusion." | 3.70 | Usefulness of head-up tilt test in the evaluation and management of unexplained syncope or pre-syncope. ( Fang, BR; Kuo, LT, 2000) |
| " At this time the remission of spinal anaesthesia was nearly complete, and the patient had received his daily dose of 150 mg atenolol because of a current hypertension 80 minutes earlier." | 3.69 | [Syncope with postoperative beta blocker medication after spinal anesthesia--case report]. ( Seitz, W; Selhorst-Kiss, S, 1997) |
| "Syncope occurred in nine patients (36%) during the baseline tilt and in seven patients (28%) during isoproterenol infusion (total positives 64%)." | 3.68 | Recurrent unexplained syncope in the elderly: the use of head-upright tilt table testing in evaluation and management. ( Elliott, L; Grubb, BP; Hahn, H; Madu, E; Samoil, D; Temesy-Armos, P; Wolfe, D, 1992) |
| "Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare arrythmogenic disease characterized by exercise--or stress--induced ventricular tachyarrythmias, syncope, or sudden death, usually in the pediatric age group." | 1.35 | Catecholaminergic polymorphic ventricular tachycardia in a child: a case report. ( De Wolf, D; Garabedian, L; Panzer, J; Verryckt, A, 2008) |
| "A vasovagal syncope was considered as the most likely diagnosis." | 1.33 | ["Coffee swallowing syncope"]. ( Schmidt, Ch; Sendi, P, 2005) |
| "Neurally mediated hypotension is now recognised as a common cause of otherwise unexplained recurrent syncope, but has not been reported in association with chronic fatigue." | 1.29 | Is neurally mediated hypotension an unrecognised cause of chronic fatigue? ( Bou-Holaigah, I; Calkins, H; Kan, JS; Rowe, PC, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.33) | 18.7374 |
| 1990's | 18 (60.00) | 18.2507 |
| 2000's | 5 (16.67) | 29.6817 |
| 2010's | 6 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Juraschek, SP | 1 |
| Simpson, LM | 1 |
| Davis, BR | 1 |
| Beach, JL | 1 |
| Ishak, A | 1 |
| Mukamal, KJ | 1 |
| Abu-Zeitone, A | 1 |
| Peterson, DR | 1 |
| Polonsky, B | 1 |
| McNitt, S | 1 |
| Moss, AJ | 1 |
| Fagundes, A | 1 |
| DE Magalhaes, LP | 1 |
| Russo, M | 1 |
| Xavier, E | 1 |
| Paulison, B | 1 |
| Léos, CL | 1 |
| Mikesell, CE | 1 |
| Atkinson, DE | 1 |
| Rachman, BR | 1 |
| Hwang, SW | 1 |
| Thomas, JG | 1 |
| Whitehead, WE | 1 |
| Curry, DJ | 1 |
| Dauser, RC | 1 |
| Kim, ES | 1 |
| Luerssen, TG | 1 |
| Jea, A | 1 |
| Meurs, KM | 1 |
| Spier, AW | 1 |
| Wright, NA | 1 |
| Atkins, CE | 1 |
| DeFrancesco, TC | 1 |
| Gordon, SG | 1 |
| Hamlin, RL | 1 |
| Keene, BW | 1 |
| Miller, MW | 1 |
| Moise, NS | 1 |
| Sendi, P | 1 |
| Schmidt, Ch | 1 |
| Garabedian, L | 1 |
| Verryckt, A | 1 |
| Panzer, J | 1 |
| De Wolf, D | 1 |
| Laakso, M | 1 |
| Pentikäinen, PJ | 1 |
| Pyörälä, K | 1 |
| Neuvonen, PJ | 1 |
| Mahanonda, N | 1 |
| Bhuripanyo, K | 1 |
| Kangkagate, C | 1 |
| Wansanit, K | 1 |
| Kulchot, B | 1 |
| Nademanee, K | 1 |
| Chaithiraphan, S | 1 |
| Scott, WA | 1 |
| Pongiglione, G | 1 |
| Bromberg, BI | 1 |
| Schaffer, MS | 1 |
| Deal, BJ | 1 |
| Fish, FA | 1 |
| Dick, M | 1 |
| Calkins, H | 2 |
| Seifert, M | 1 |
| Morady, F | 1 |
| Rowe, PC | 1 |
| Bou-Holaigah, I | 1 |
| Kan, JS | 1 |
| Aarøe, J | 1 |
| Hansen, JB | 1 |
| Klein, GJ | 1 |
| Lerman, BB | 1 |
| Tavel, ME | 1 |
| Rashtian, MY | 1 |
| Bhandari, AK | 1 |
| Arad, M | 1 |
| Solomon, A | 1 |
| Roth, A | 1 |
| Atsmon, J | 1 |
| Rabinowitz, B | 1 |
| Freitas, J | 1 |
| Costa, O | 1 |
| Carvalho, MJ | 1 |
| Falcão de Freitas, A | 1 |
| de Meester, A | 1 |
| Chaudron, JM | 1 |
| de Roy, L | 1 |
| Selhorst-Kiss, S | 1 |
| Seitz, W | 1 |
| Fang, BR | 1 |
| Kuo, LT | 1 |
| Kelkar, PN | 1 |
| Eirís-Puñal, J | 1 |
| Rodríguez-Núñez, A | 1 |
| Fernández-Martínez, N | 1 |
| Fuster, M | 1 |
| Castro-Gago, M | 1 |
| Martinón, JM | 1 |
| Grubb, BP | 1 |
| Wolfe, D | 1 |
| Samoil, D | 1 |
| Madu, E | 1 |
| Temesy-Armos, P | 1 |
| Hahn, H | 1 |
| Elliott, L | 1 |
| Thilenius, OG | 2 |
| Ryd, KJ | 1 |
| Husayni, J | 1 |
| Brignole, M | 1 |
| Menozzi, C | 1 |
| Gianfranchi, L | 1 |
| Lolli, G | 1 |
| Bottoni, N | 1 |
| Oddone, D | 1 |
| Perry, JC | 2 |
| Garson, A | 2 |
| Friedman, RA | 1 |
| Moak, JP | 1 |
| Quinones, JA | 1 |
| Husayni, TS | 1 |
| Novak, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| [NCT00000542] | Phase 3 | 0 participants | Interventional | 1993-08-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for atenolol and Drop Attack
| Article | Year |
|---|---|
Potential cardiotoxic reaction involving rivastigmine and beta-blockers: a case report and review of the literature.
Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Bradycardia; Cholinesterase Inhibitors; Drug Interactio | 2010 |
Prolonged QT syndrome and sedation: a case report and a review of the literature.
Topics: Arrhythmias, Cardiac; Atenolol; Child, Preschool; Conscious Sedation; Electrocardiography; Emergency | 2011 |
5 trials available for atenolol and Drop Attack
| Article | Year |
|---|---|
Comparison of the effects of four antiarrhythmic treatments for familial ventricular arrhythmias in Boxers.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atenolol; Dog Diseases; Dogs; Drug Therapy, C | 2002 |
Randomized double-blind, placebo-controlled trial of oral atenolol in patients with unexplained syncope and positive upright tilt table test results.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Double-Blind Method; Female; Humans; Male; Middle Aged | 1995 |
Randomized comparison of atenolol and fludrocortisone acetate in the treatment of pediatric neurally mediated syncope.
Topics: Adolescent; Atenolol; Child; Electrocardiography; Fludrocortisone; Humans; Syncope; Tilt-Table Test | 1995 |
Usefulness of the head-upright tilt test for distinguishing syncope and epilepsy in children.
Topics: Adolescent; Age Factors; Anticonvulsants; Atenolol; Child; Diagnosis, Differential; Diagnostic Error | 2001 |
A controlled trial of acute and long-term medical therapy in tilt-induced neurally mediated syncope.
Topics: Adult; Atenolol; Bandages; Dihydroergotamine; Domperidone; Female; Humans; Isoproterenol; Male; Midd | 1992 |
23 other studies available for atenolol and Drop Attack
| Article | Year |
|---|---|
Effects of Antihypertensive Class on Falls, Syncope, and Orthostatic Hypotension in Older Adults: The ALLHAT Trial.
Topics: Accidental Falls; Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Atenolol; Chlorthali | 2019 |
Efficacy of different beta-blockers in the treatment of long QT syndrome.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Atenolol; Child; Child, Preschool; Death, Sudden, Ca | 2014 |
Pharmacological treatment of electrical storm in cathecolaminergic polymorphic ventricular tachycardia.
Topics: Adolescent; Anti-Arrhythmia Agents; Atenolol; Defibrillators, Implantable; Drug Therapy, Combination | 2010 |
Left thorascopic sympathectomy for refractory long QT syndrome in children.
Topics: Adolescent; Adrenergic beta-Antagonists; Atenolol; Cardiac Surgical Procedures; Child; Child, Presch | 2011 |
["Coffee swallowing syncope"].
Topics: Adrenergic beta-Antagonists; Adult; Angiotensin Receptor Antagonists; Antihypertensive Agents; Ateno | 2005 |
Catecholaminergic polymorphic ventricular tachycardia in a child: a case report.
Topics: Anti-Arrhythmia Agents; Atenolol; Catecholamines; Child, Preschool; Diagnosis, Differential; Exercis | 2008 |
Prolongation of the Q-T interval caused by sotalol--possible association with ventricular tachyarrhythmias.
Topics: Adrenergic beta-Antagonists; Atenolol; Electrocardiography; Heart Ventricles; Humans; Kinetics; Male | 1981 |
Clinical presentation and long-term follow-up of athletes with exercise-induced vasodepressor syncope.
Topics: Adolescent; Adult; Age of Onset; Atenolol; Bradycardia; Disopyramide; Drug Combinations; Exercise; E | 1995 |
Is neurally mediated hypotension an unrecognised cause of chronic fatigue?
Topics: Adolescent; Atenolol; Autonomic Nervous System Diseases; Blood Pressure; Child; Disopyramide; Fatigu | 1995 |
[Tilt-induced vasovagal syncope].
Topics: Adult; Atenolol; Female; Humans; Hypotension, Orthostatic; Posture; Recurrence; Syncope; Vagus Nerve | 1994 |
Syncope: common clinical problem of diagnosis and management.
Topics: Atenolol; Bradycardia; Female; Humans; Hypotension, Orthostatic; Middle Aged; Recurrence; Syncope | 1994 |
Worsening of neurocardiogenic syncope by beta-blockers.
Topics: Adult; Atenolol; Humans; Male; Recurrence; Syncope | 1993 |
Postexercise syncope: evidence for increased activity of the sympathetic nervous system.
Topics: Adult; Arousal; Atenolol; Bradycardia; Epinephrine; Exercise Test; Heart Arrest; Humans; Hypertensio | 1993 |
High altitude-related neurocardiogenic syncope.
Topics: Adrenergic beta-Antagonists; Adult; Altitude; Atenolol; Female; Heart Rate; Humans; Sympathetic Nerv | 1996 |
Usefulness of isoproterenol in the induction of clinical sustained ventricular tachycardia during electrophysiological study.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Aged; Atenolol; Cardiac Pacing, Artificial; E | 1997 |
[Syncope with postoperative beta blocker medication after spinal anesthesia--case report].
Topics: Adrenergic beta-Antagonists; Anesthesia, Spinal; Atenolol; Blood Pressure; Drug Interactions; Heart | 1997 |
Usefulness of head-up tilt test in the evaluation and management of unexplained syncope or pre-syncope.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Atenolol; Child; Child, Preschool; Female; Humans; Isopr | 2000 |
Atenolol induced high grade AV block.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Atenolol; Heart Block; Humans; Hypertension; Male; | 1998 |
Recurrent unexplained syncope in the elderly: the use of head-upright tilt table testing in evaluation and management.
Topics: Aged; Aged, 80 and over; Atenolol; Beds; Blood Pressure; Disopyramide; Drug Therapy, Combination; El | 1992 |
Variations in expression and treatment of transient neurocardiogenic instability.
Topics: Adolescent; Adult; Atenolol; Blood Pressure; Child; Child, Preschool; Female; Heart Rate; Humans; Ma | 1992 |
The child with recurrent syncope: autonomic function testing and beta-adrenergic hypersensitivity.
Topics: Adolescent; Adrenergic beta-Antagonists; Atenolol; Autonomic Nervous System; Child; Epinephrine; Fem | 1991 |
Bradycardia and syncope in children not controlled by pacing: beta-adrenergic hypersensitivity.
Topics: Adrenergic beta-Antagonists; Atenolol; Autonomic Nervous System; Bradycardia; Cardiac Pacing, Artifi | 1991 |
Tilt test for diagnosis of unexplained syncope in pediatric patients.
Topics: Adolescent; Adult; Atenolol; Blood Pressure; Child; Electrocardiography; Female; Heart Rate; Humans; | 1991 |